科创医药指数ETF（588700）盘中溢价，华熙生物涨超3%，机构：长期看医药行业有望走出全球性大公司

Core Viewpoint - The ChiNext Index and Shenzhen Component Index both fell over 1% on May 15, indicating a bearish trend in the market [1] Group 1: ETF Performance - The Sci-Tech Medicine Index ETF (588700) experienced a volatile trading session, closing down 0.42% with a premium rate of 0.04% [1] - Notable stocks within the ETF, such as Huaxi Biological and Huaheng Biological, saw gains exceeding 3%, while other stocks like Ailis, SanSheng GuoJian, BaiLi TianHeng, YiFang Biological-U, and RongChang Biological also experienced upward movement [1] Group 2: Fund Flows and Market Outlook - The Sci-Tech Medicine Index ETF (588700) recorded a net inflow of funds yesterday, reflecting investor interest [2] - The ETF closely tracks the Shanghai Stock Exchange Sci-Tech Board Biomedicine Index, which includes 50 large-cap companies in biomedicine, biomedical engineering, bio-agriculture, and other related sectors [2] - According to CITIC Securities research, the pharmaceutical, CXO, upstream, and scientific service sectors performed well last week, with a positive outlook for quality innovative drug companies through 2025 [2] - The report emphasizes the importance of focusing on cutting-edge technologies in pharmaceuticals and medical devices, while also acknowledging the challenges posed by international expansion [2]